The Company was founded in 2008 by a group of Polish scientists who have developed a breakthrough method of using liquid crystals for diagnosing breast cancer. The researchers have created a unique mixture of liquid crystal compounds and an innovative liquid crystal emulsion formula that have been used to develop a signature method of manufacturing liquid crystal matrices using Continuous Liquid Crystals Film (CLCF) technology. The objective of the Company’s activities is the roll-out of the TESTER, an innovative, worldwide-unique device for early diagnostics of breast cancer.

The results of research performed in 2009-2010 gave rise to registering the device in 2010 with the Office for Registration of Medicinal Products, Medical Devices and Biocides as a class I medical device. Upon registration, the Company was free to sell the product to the markets of the European Union countries. In 2011 the TESTER was submitted to EUDAMED, a European database for medical devices maintained by the European Commission.